Webinar | May 4, 2021

Are You Ready To Begin Planning Your IND Submission?

Submitting an Investigational New Drug (IND) application to the US FDA is a significant step in the development of a new drug or biologic product. But, are you ready?

In this webinar, Veristat experts explore the minimum required content for an IND submission and the strategic considerations for developing more than the minimum necessary data before filing an IND. Hear from regulatory experts responsible for dozens of IND submissions who cover considerations such as selecting a target indication, seeking pre-IND advice from FDA, deciding whether to use US or non-US sites for early clinical research and more. The direction provided will help you determine whether you are ready to submit your IND and take the next step in the development of your product

This webinar will help you better understand:

  • Drug development overview
  • Purpose of an IND
  • When do you have enough data?
  • Value of a pre-IND meeting
VIEW THE WEBINAR!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene